These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1701908

  • 1. [Molecular structure and immunochemistry of streptococcal M-protein].
    Ookuni H.
    Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W, Haanes-Fritz E, Cleary PP, Seyer JM, Dale JB, Beachey EH.
    J Immunol; 1987 Nov 01; 139(9):3084-90. PubMed ID: 2444650
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
    Kaminskiĭ GD, Beliakov VD.
    Vestn Akad Med Nauk SSSR; 1986 Nov 01; (7):10-7. PubMed ID: 2428180
    [No Abstract] [Full Text] [Related]

  • 10. The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man.
    Beachey EH, Stollerman GH.
    Trans Assoc Am Physicians; 1972 Nov 01; 85():212-21. PubMed ID: 4121774
    [No Abstract] [Full Text] [Related]

  • 11. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
    Johnsson E, Berggård K, Kotarsky H, Hellwage J, Zipfel PF, Sjöbring U, Lindahl G.
    J Immunol; 1998 Nov 01; 161(9):4894-901. PubMed ID: 9794423
    [Abstract] [Full Text] [Related]

  • 12. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
    Carlsson F, Berggård K, Stålhammar-Carlemalm M, Lindahl G.
    J Exp Med; 2003 Oct 06; 198(7):1057-68. PubMed ID: 14517274
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF.
    Nat Med; 2000 Apr 06; 6(4):455-9. PubMed ID: 10742155
    [Abstract] [Full Text] [Related]

  • 16. Application of immunoproteomics to analysis of post-translational processing of the antiphagocytic M protein of Streptococcus.
    Romer TG, Boyle MD.
    Proteomics; 2003 Jan 06; 3(1):29-35. PubMed ID: 12548631
    [Abstract] [Full Text] [Related]

  • 17. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
    Sandin C, Carlsson F, Lindahl G.
    Mol Microbiol; 2006 Jan 06; 59(1):20-30. PubMed ID: 16359315
    [Abstract] [Full Text] [Related]

  • 18. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A, McShan WM, Salmi D, Kaplan EL, Johnson DR, Stevens DL.
    J Infect Dis; 1999 Dec 06; 180(6):1921-8. PubMed ID: 10558949
    [Abstract] [Full Text] [Related]

  • 19. Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.
    Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I.
    J Med Chem; 2004 Jul 29; 47(16):4100-4. PubMed ID: 15267249
    [Abstract] [Full Text] [Related]

  • 20. Streptococcal vaccines revisited.
    Stollerman GH.
    J Lab Clin Med; 1978 Jun 29; 91(6):872-80. PubMed ID: 77303
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.